<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Epilepsy MeG-CLS-056</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="epilepsy">Epilepsy</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Epilepsy is a chronic brain disorder characterized by a predilection to having afebrile epileptic seizures. Most epilepsy is of unknown cause (idiopathic epilepsy). Majority of people with epilepsy live in LMICs like The Gambia. Epilepsy can significantly impair quality of life and cause social stigma. Late presentation and poor adherence to treatment increases the risk of status epilepticus and sudden unexpected death in epilepsy.</p>
<p>This guideline covers the diagnoses and treatment of epilepsy and status epilepticus.</p>
<h3 id="target-users">Target users</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
</ul>
<h3 id="target-area-of-use">Target area of use </h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Gate Clinic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient Department</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
</ul>
<h3 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h3>
<p>The diagnosis of epilepsy requires two <em>unprovoked</em> epileptic seizures occurring at least 24 hours apart or a single <em>unprovoked</em> epileptic seizure with an underlying predisposition to recurrence. Epileptic seizures are classified based on onset, awareness and symptoms. The type of seizures and other findings on clinical examination assist in the choice of drug therapy in epilepsy.</p>
<p>The diagnosis of epilepsy is clinical. EEG may assist in classifying seizure type. Other investigations may be requested to detect underlying causes or for monitoring patients on treatment.</p>
<p>The goal of treatment is no seizures and no side effects. Anticonvulsant monotherapy is preferred. Patients and their caregivers should be involved in decision-making to improve adherence to drugs and lifestyle measures prescribed.</p>
<p>Special situations discussed include status epilepticus, epilepsy in women of childbearing age including pregnancy, patients with first unprovoked seizure, and non-epileptic seizures.</p>
<h3 id="limitations">Limitations </h3>
<p>EEG is not currently available in The Gambia.</p>
<h2 id="presenting-symptoms-and-signs">Presenting symptoms and signs</h2>
<h2 id="an-epileptic-seizure-is-a-transient-motor-sensory-or-psychic-manifestation-that-results-from-an-abnormal-paroxysmal-electrical-discharge-in-the-brain.-presence-of-epileptic-seizures-does-not-necessarily-imply-epilepsy-is-present-as-many-acute-conditions-can-present-with-epileptic-seizures-as-symptoms-acute-symptomatic-seizures.-however-significant-brain-injury-from-these-conditions-may-ultimately-result-in-epilepsy-secondary-or-symptomatic-epilepsy.">An epileptic seizure is a transient motor, sensory or psychic manifestation that results from an abnormal paroxysmal electrical discharge in the brain. Presence of epileptic seizures does not necessarily imply epilepsy is present as many acute conditions can present with epileptic seizures as symptoms (acute symptomatic seizures). However, significant brain injury from these conditions may ultimately result in epilepsy (secondary or symptomatic epilepsy).</h2>
<h2 id="onset">Onset</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Seizures may be focal in onset (one side of the brain) or generalized (both sides of the brain).</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Focal seizures may become secondarily generalized. This initial focal component may be missed if eye-witnesses or the patient are not specifically questioned. An “aura” preceding a generalized seizure is considered a focal seizure.</p>
</div></li>
</ul></li>
</ul>
<h2 id="awareness">Awareness</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>In generalized seizures, the patient is unconscious or has complete loss of awareness.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Focal seizures may present with intact awareness (‘focal aware seizure”, formerly called “simple partial seizure”) or with impaired awareness.</p>
</div></li>
</ul>
<h2 id="symptoms">Symptoms</h2>
<p>Seizures may present as motor or non-motor symptoms</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Focal motor seizures may present as abnormal involuntary movements of the eyes, face, head or limbs;</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Focal non-motor seizures may present as abnormal sensations (strange odours, paraesthesia, abdominal pain) or as changes in cognition, emotions or behaviour.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Generalized motor seizures are most commonly tonic-clonic but other forms including tonic, atonic, clonic and myoclonic seizures may occur alone or in combination.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Generalized non-motor seizures usually present as absence seizures with brief episodes of loss of awareness. Automatisms may be present but are not considered motor seizures.</p>
</div></li>
</ul>
<h2 id="others">Others</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Seizures may occur alone, as part of a recognizable epilepsy syndrome or as a component of a broader neurological disorder.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Not all seizure-like activities are epileptic in nature; tics, tremors, spasms, non-epileptic myoclonus, syncope and psychogenic non-epileptic seizures among many other conditions may mimic epileptic seizures.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>History should include questions about</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Symptoms</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Warning signs (“aura’) before episode</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nature of activity during episode</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Awareness during episode and ability to recall after episode</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Patient’s state and time to full recovery after episode</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Duration and frequency of episodes</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Triggers</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Response to any previous therapy</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>Prenatal, perinatal and developmental assessment.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>History of severe illness or severe head trauma</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ongoing drug use (illicit drugs, anticonvulsants)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Consanguinity and family history of seizures.</p>
</div></li>
</ul></li>
<li><div data-custom-style="List Paragraph">
<p>There is room for uncertainty when describing epilepsy in the absence of adequate information e.g generalized tonic-clonic epilepsy with <em>unknown onset</em>, focal epilepsy, <em>awareness unknown</em>.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Eye-witness accounts and video recordings are very helpful in diagnosis.</p>
</div></li>
</ul>
<h2 id="examination-findings">Examination findings</h2>
<p>Examination of patients with epilepsy should asses cardiac and neurological function, including mental status. Examination of the skin may reveal abnormalities associated with some neurological syndromes. Patients with generalized epilepsy may show signs of past or recent trauma such as scars, bruises and lacerations.</p>
<h2 id="management">Management </h2>
<p><strong><span class="underline">Diagnosis</span></strong></p>
<p>Diagnosis of epilepsy is based on clinical findings. Investigations may be carried out to detect underlying causes and to support the diagnosis where features are not typical.</p>
<p>Video EEG is the gold standard for classifying seizure types and detecting psychogenic non-epileptic seizures. It is expensive and unavailable in our setting.</p>
<p>Inter-ictal EEG can be done at Dakar, if necessary. Inter-ictal EEG alone should not be used to differentiate epileptic seizures from other diagnoses as false-positive findings can occur in persons without epilepsy.</p>
<p>CT scan or MRI can be requested if the patient has abnormal neurologic findings. MRI is available in Dakar and may be informative in patients with difficult-to-control focal-onset epilepsy. These tests should not be routinely requested for patients with a clinical diagnosis of idiopathic generalized epilepsy.</p>
<p>Lumbar puncture for CSF analysis is useful in patients with suspected meningitis, encephalitis, subarachnoid haemorrhage or prolonged alteration in consciousness.</p>
<div data-custom-style="numbered-paragraph">
<p>Adults with suspected epilepsy should have a standard electrocardiogram done. Young adults and children may also have an ECG done if the diagnosis of epilepsy is uncertain.</p>
</div>
<div data-custom-style="Normal (Web)">
<p>Adults with epilepsy should do the following tests every 2 years:</p>
</div>
<ul>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Full blood count</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Electrolytes, urea and creatinine,</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Liver function tests</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Serum calcium</p>
</blockquote>
</div></li>
</ul>
<p><strong><span class="underline">Treatment</span></strong></p>
<p>Patients with suspected epilepsy should be sent to the outpatient department for review by a doctor.</p>
<p>The goal of epilepsy treatment is to stop seizures completely without causing adverse effects from treatment (“no seizures, no side-effects”). Studies have shown that this can be achieved in up to 60% of patients. Up to 70% of patients remain seizure-free when medications are discontinued after 2 - 5 years of treatment.</p>
<p>To limit adverse events and drug interactions, treatment with a single appropriate anticonvulsant drug is preferred. Choosing this drug will require accurate classification of the type of epilepsy and assessing its suitability for the particular patient. Patients who remain uncontrolled on a single drug at maximum tolerated dose can have another appropriate drug added to the regimen. The new drug should be titrated to its maximum effective dose after which the old drug is tapered off gradually.</p>
<p>If the second drug is not helpful, any of the two drugs can be tapered off first and then a third drug started. If attempts at combination therapy are unhelpful, it is best to stay with the most effective regimen tolerated by the patient.</p>
<p>Lamotrigine and valproate are broad-spectrum anticonvulsants but are best reserved for generalized onset epilepsy. Valproate is notoriously teratogenic. It should be used by girls and women of childbearing age only if there is no alternative on the condition that they are counselled fully on the risk-benefit and the need for effective contraception. Valproate is significantly more expensive than carbamazepine. Lamotrigine is even more expensive.</p>
<p>Epilepsy in adults is most commonly focal in onset; this type of epilepsy generally responds to carbamazepine. Myoclonic seizures and absence seizures may be worsened by carbamazepine and should be treated with valproate.</p>
<table>
<thead>
<tr class="header">
<th><strong>Epilepsy Syndrome</strong></th>
<th><strong>First Line</strong></th>
<th><strong>Alternative / Adjunctive</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Focal</td>
<td>Carbamazepine</td>
<td><p>Lamotrigine</p>
<p>Sodium valproate</p></td>
</tr>
<tr class="even">
<td>Generalized tonic-clonic</td>
<td>Sodium valproate</td>
<td><p>Lamotrigine</p>
<p>Carbamazepine</p></td>
</tr>
<tr class="odd">
<td>Unclassified</td>
<td>Sodium valproate</td>
<td>Lamotrigine</td>
</tr>
<tr class="even">
<td>Absence</td>
<td><p>Ethosuximide (not readily available),</p>
<p>Sodium valproate</p></td>
<td>Lamotrigine</td>
</tr>
<tr class="odd">
<td>Myoclonic</td>
<td>Sodium valproate</td>
<td></td>
</tr>
<tr class="even">
<td>Atonic or Tonic</td>
<td>Sodium valproate</td>
<td></td>
</tr>
<tr class="odd">
<td>Infantile spasms</td>
<td><p>Vigabatrin (not readily available),</p>
<p>ACTH (not readily available),</p>
<p>Prednisolone</p></td>
<td></td>
</tr>
</tbody>
</table>
<p>Discuss the nature of the diagnosis and treatment with patient and caregivers. Lifestyle modifications and restrictions should be discussed including hazards such as using dangerous equipment, driving, working at heights, cooking over open flames and swimming. Drug adherence and the risks associated with sudden drug discontinuation should be emphasized.</p>
<p>If the patient is seizure-free for 2 to 5 years, drug therapy can be tapered off over a 3-month period at least. For patients on multiple drugs, discontinue one drug at a time. The risks of drug discontinuation including the possibility of relapse should be discussed and a clear plan agreed on with the patient.</p>
<p><strong><span class="underline">Special Situations</span></strong></p>
<p><strong>Status Epilepticus:</strong></p>
<p>Generalized convulsive status epilepticus is a life-threatening emergency. The typical patient with status epilepticus is one who suddenly discontinued anti-epileptic medications. Structural and metabolic disturbances can also lead to status epilepticus.</p>
<p>Generalized convulsive status epilepticus is diagnosed when:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>A generalized tonic-clonic seizure lasts for more than 5 minutes (Note that this period is for active fitting only and does not include the post-ictal phase of sleep or confusion), <strong>or</strong></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>A patient has a second generalized tonic-clonic seizure without recovering fully from the first seizure.</p>
</div></li>
</ul>
<p><em><strong>Treatment:</strong></em></p>
<p><em>1st stage (0−10 minutes)</em></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Secure airway and resuscitate</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Administer oxygen</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Assess cardiorespiratory function</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Establish intravenous access</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Administer glucose (50 ml of 50% solution) in adults (with intravenous thiamine 100 mg if there is any feature suggestive of alcoholism or malnutrition).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Call the doctor on call</p>
</div></li>
</ul>
<p><em>2nd stage (0−30 minutes)</em></p>
<p>Commence regular monitoring of vital signs</p>
<p>Send samples for emergency investigations</p>
<p>Consider the possibility of non-epileptic seizures</p>
<p>Emergency anticonvulsant therapy with IV diazepam</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Give 0.15 mg/kg of IV diazepam over 5 minutes or 0.5 mg/kg PR (draw up the iv solution and use the syringe without an attached needle to deliver the drug PR).</p>
</div></li>
</ul>
<p>Give usual anti-epileptic medication via NG tube if already on treatment for epilepsy.</p>
<p>Continue emergency anticonvulsant therapy with :</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Phenytoin infusion at a dose of 20 mg/kg at a rate of 50 mg/minute (do NOT mix with dextrose-containing infusion; use normal saline).</p>
</div></li>
</ul>
<div data-custom-style="List Paragraph">
<p>OR</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p>IV phenobarbital bolus of 15 mg/kg at a rate of 100 mg/minute if phenytoin is unavailable.</p>
</div></li>
</ul>
<p>Urethral catheterization</p>
<p><em><br />
</em></p>
<p><em>3rd stage (0−60 minutes)</em></p>
<p>Identify aetiology of status epilepticus and treat medical complications.</p>
<p>If seizures persist 20 minutes after initial phenytoin infusion, give additional 10 mg/kg of phenytoin infusion.</p>
<p><em>4th stage (30−90 minutes)</em></p>
<p>If still in status epilepticus 20 minutes after second phenytoin infusion, give IV phenobarbital at 15 mg/kg.</p>
<p><em>Emergency investigations</em></p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Blood glucose</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Urinalysis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Serum electrolytes, urea and creatinine</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Liver function tests</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Serum calcium and magnesium</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Full blood count</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Clotting profile</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chest radiograph may be needed to check for possible aspiration.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Blood culture (if clinically indicated)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Cranial CT Scan (if clinically indicated)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Lumbar puncture for CSF analysis (if clinically indicated)</p>
</div></li>
</ul>
<p>Ideally, patients should have continuous EEG monitoring, toxicologic screening, arterial blood gases and assay of anticonvulsant levels performed but these are not presently feasible.</p>
<p><strong>Girls and women of child bearing age:</strong></p>
<p>Many anticonvulsant drugs reduce the effectiveness of oral contraceptive pills. Other forms of contraception should be recommended.</p>
<p>Girls and women of childbearing age on treatment for epilepsy should be prescribed 5 mg of folic acid daily.</p>
<p>Anticonvulsant medications should not be switched during pregnancy even when the mother is on sodium valproate. Switching drugs increases the risks to both the mother and her fetus. Pregnant patients with epilepsy should be referred to the obstetrician early in the antenatal period.</p>
<p><strong>Patient with first unprovoked first seizure:</strong></p>
<p>Although the risk of development of epilepsy is higher in persons who have had a first unprovoked seizure, it is recommended that anti-epileptic drugs be withheld until a second unprovoked seizure occurs.</p>
<p><strong>Non-epileptic seizures:</strong></p>
<p>Some patients with psychological or psychiatric problems may present with non-epileptic seizures (pseudoseizures, psychogenic seizures). Other patients may produce seizure-like movements either subconsciously (factitious disorder) or intentionally (malingering).</p>
<p>Some of these patients actually have an underlying epilepsy syndrome while others may have been misdiagnosed and wrongly placed on epilepsy treatment.</p>
<p>It is difficult to differentiate non-epileptic seizures from true seizures without video-EEG monitoring. However, presence of severe tongue biting, an ictal cry and incontinence makes non-epileptic seizures unlikely.</p>
<p>The following features are not definitive but suggest a non-epileptic seizure especially when they occur together:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Eyes closed during seizure and resistance to passive eye-opening by examiner</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Patient’s hand fails to fall on face when dropped over the head</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Side-to-side head movements during seizure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Pelvic thrusts during seizure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Seizures occurring with audiences (consulting room, waiting room, ward rounds)</p>
</div></li>
</ul>
<p>Patients with suspected non-epileptic seizures should do an EEG and undergo psychological evaluation. Maintain their current therapy status until reviewed.</p>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><h2 id="monitor-closely-and-document-seizures-which-may-be-subtle-e.g-lip-twitching">Monitor closely and document seizures which may be subtle (e.g lip twitching)</h2></li>
<li><h2 id="monitor-and-document-vital-signs-fluids-and-level-of-consciousness">Monitor and document vital signs, fluids and level of consciousness</h2></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Nurse patients having generalized seizures in left lateral position with bed rails raised up.</p>
</blockquote>
</div></li>
<li><div data-custom-style="List Paragraph">
<blockquote>
<p>Do not force any object between the teeth during a seizure</p>
</blockquote>
</div></li>
</ul>
<h2 id="references">References</h2>
<p>National Institute for Health and Care Excellence. Epilepsies: diagnosis and management. Clinical guideline [CG137] Published: January 2012 Last updated: April 2018. Available from: <a href="https://www.nice.org.uk/guidance/cg137"><span data-custom-style="Hyperlink">https://www.nice.org.uk/guidance/cg137</span></a> Accessed: 11th November 2018</p>
<h1 id="devinsky-o-gazzola-d-lafrance-wc-jr.-differentiating-between-nonepileptic-and-epileptic-seizures.-nat-rev-neurol.-2011-apr74210-20."><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Devinsky%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814">Devinsky O</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gazzola%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814">Gazzola D</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=LaFrance%20WC%20Jr%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21386814">LaFrance WC Jr</a>. Differentiating between nonepileptic and epileptic seizures. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21386814">Nat Rev Neurol.</a> 2011 Apr;7(4):210-20. </h1>
<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Krumholz%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057">Krumholz A</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Wiebe%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057">Wiebe S</a>, <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=Gronseth%20GS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25901057">Gronseth GS</a>. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25901057">Neurology.</a> 2015 Apr 21;84(16):1705-13.</p>
<p>Medscape. Psychogenic Nonepileptic Seizures. Available from: <a href="http://reference.medscape.com/article/1184694"><span data-custom-style="Hyperlink">http://reference.medscape.com/article/1184694</span></a> Accessed: 30 November 2018</p>
<p>Medscape. Epilepsy and Seizures. Available from: <a href="http://reference.medscape.com/article/1184846"><span data-custom-style="Hyperlink">http://reference.medscape.com/article/1184846</span></a> Accessed: 25 November 2018</p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Fatai Akemokwe</th>
<th>Date: 30 November 2018</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Karen Forrest</td>
<td>Date: 12 December 2018</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>31 January 2021</td>
</tr>
<tr class="even">
<td>1.1</td>
<td>Executive summary added</td>
<td>31 January 2021</td>
</tr>
<tr class="odd">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
